A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Cyclophosphamide's patents.
Latest Legal Activities on Cyclophosphamide's Patents
Given below is the list recent legal activities going on the following patents of Cyclophosphamide.
Activity
Date
Patent Number
Payment of Maintenance Fee, 4th Year, Large Entity
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Cyclophosphamide Generic API Manufacturers
Several generic applications have been filed for Cyclophosphamide. The first generic version for Cyclophosphamide was by Bedford Laboratories Div Ben Venue Laboratories Inc and was approved on Feb 16, 1982. And the latest generic version is by Hainan Poly Pharm Co Ltd and was approved on Dec 26, 2024.
Given below is the list of companies who have filed for
Cyclophosphamide generic, along with the locations of their manufacturing plants worldwide.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Cyclophosphamide. Given below are the
details of the strengths of this generic introduced by
Alembic.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
25MG
capsule
Prescription
ORAL
AB
Nov 10, 2022
50MG
capsule
Prescription
ORAL
AB
Nov 10, 2022
Manufacturing Plant Locations
New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
Amneal Eu Ltd has filed for 3 different strengths of generic version for Cyclophosphamide. Given below are the
details of the strengths of this generic introduced by
Amneal.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
2GM/VIAL
injectable
Prescription
INJECTION
AP
May 25, 2018
500MG/VIAL
injectable
Prescription
INJECTION
AP
May 25, 2018
1GM/VIAL
injectable
Prescription
INJECTION
AP
May 25, 2018
Manufacturing Plant Locations
New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
Country
City
Firm Name
United States
Branchburg
Amneal Pharmaceuticals, LLC
East Hanover
Amneal Pharmaceuticals LLC
Glasgow
Amneal Pharmaceuticals LLC
Hauppauge
Amneal Pharmaceuticals of New York, LLC
Brookhaven
Amneal Pharmaceuticals of New York, LLC
Paterson
Amneal Pharmaceuticals, Llc
Piscataway
Amneal Pharmaceuticals, LLC
Bridgewater
Amneal Complex Products Research LLC
India
Tal Bavla, Ahmedabad
Amneal Pharmaceuticals Pvt. Ltd.
Matoda
Amneal Pharmaceuticals Private Ltd.
Hyderabad
Amneal Oncology Private Limited
Ahmedabad
Amneal Pharmaceuticals Private Ltd.
3. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 2 different strengths of generic version for Cyclophosphamide. Given below are the
details of the strengths of this generic introduced by
Ani Pharms.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
25MG
capsule
Discontinued
ORAL
N/A
Mar 19, 2018
50MG
capsule
Discontinued
ORAL
N/A
Mar 19, 2018
4. BAXTER HLTHCARE
Baxter Healthcare Corp has filed for 5 different strengths of generic version for Cyclophosphamide. Given below are the
details of the strengths of this generic introduced by
Baxter Hlthcare.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
200MG/VIAL
injectable
Discontinued
INJECTION
N/A
Jul 3, 1986
500MG/VIAL
(reference standard)
injectable
Prescription
INJECTION
AP
May 21, 2008
100MG/VIAL
injectable
Discontinued
INJECTION
N/A
Jul 3, 1986
1GM/VIAL
(reference standard)
injectable
Prescription
INJECTION
AP
May 21, 2008
2GM/VIAL
(reference standard)
injectable
Prescription
INJECTION
AP
May 21, 2008
5. BEDFORD
Bedford Laboratories Div Ben Venue Laboratories Inc has filed for 5 different strengths of generic version for Cyclophosphamide. All of these versions come by the name NEOSAR. Given below are the
details of the strengths of this generic introduced by
Bedford.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
200MG/VIAL
injectable
Discontinued
INJECTION
N/A
Feb 16, 1982
500MG/VIAL
injectable
Discontinued
INJECTION
N/A
Feb 16, 1982
100MG/VIAL
injectable
Discontinued
INJECTION
N/A
Feb 16, 1982
1GM/VIAL
injectable
Discontinued
INJECTION
N/A
Jul 8, 1983
2GM/VIAL
injectable
Discontinued
INJECTION
N/A
Mar 30, 1989
Manufacturing Plant Locations
New
Bedford's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bedford as present at those locations.
Country
City
Firm Name
United States
Bedford
Bedford Research Foundation, Inc.
Shelbyville
Bedford Cheese Store Inc
Curryville
Bedford Farm Bureau Cooperative
6. CIPLA
Cipla Ltd has filed for 2 different strengths of generic version for Cyclophosphamide. Given below are the
details of the strengths of this generic introduced by
Cipla.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
25MG
capsule
Prescription
ORAL
AB
Jan 18, 2019
50MG
capsule
Prescription
ORAL
AB
Jan 18, 2019
Manufacturing Plant Locations
New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
Country
City
Firm Name
India
Mumbai
Cipla Limited
Bengaluru
Cipla Limited
Pithampur, District Dhar
Cipla Limited
Raigad
Cipla Limited
Vasco Da Gama
Cipla Limited
Kurkumbh Village, Dist. Pune
Cipla, Ltd.
Bangalore
Cipla Ltd.
7. EPIC PHARMA LLC
Epic Pharma Llc has filed for 3 different strengths of generic version for Cyclophosphamide. Given below are the
details of the strengths of this generic introduced by
Epic Pharma Llc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
500MG/VIAL
injectable
Prescription
INJECTION
AP
Dec 19, 2024
1GM/VIAL
injectable
Prescription
INJECTION
AP
Dec 19, 2024
2GM/VIAL
injectable
Prescription
INJECTION
AP
Dec 19, 2024
8. HAINAN POLY
Hainan Poly Pharm Co Ltd has filed for 3 different strengths of generic version for Cyclophosphamide. Given below are the
details of the strengths of this generic introduced by
Hainan Poly.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
500MG/VIAL
injectable
Prescription
INJECTION
AP
Dec 26, 2024
1GM/VIAL
injectable
Prescription
INJECTION
AP
Dec 26, 2024
2GM/VIAL
injectable
Prescription
INJECTION
AP
Dec 26, 2024
Manufacturing Plant Locations
New
Hainan Poly's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Hainan Poly as present at those locations.
Country
City
Firm Name
China
Haikou
Hainan Poly Pharm. Co., Ltd.
9. HENGRUI PHARMA
Jiangsu Hengrui Pharmaceuticals Co Ltd has filed for 3 different strengths of generic version for Cyclophosphamide. Given below are the
details of the strengths of this generic introduced by
Hengrui Pharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
500MG/VIAL
injectable
Prescription
INJECTION
AP
Oct 31, 2014
1GM/VIAL
injectable
Prescription
INJECTION
AP
Oct 31, 2014
2GM/VIAL
injectable
Prescription
INJECTION
AP
Oct 31, 2014
10. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Cyclophosphamide. Given below are the
details of the strengths of this generic introduced by
Hikma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
500MG/VIAL
injectable
Prescription
INJECTION
AP
Dec 18, 2023
1GM/VIAL
injectable
Prescription
INJECTION
AP
Dec 18, 2023
2GM/VIAL
injectable
Prescription
INJECTION
AP
Dec 18, 2023
Manufacturing Plant Locations
New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country
City
Firm Name
United States
Dayton
Hikma Injectables USA Inc
Eatontown
Hikma Pharmaceuticals USA, Inc.
Carlsbad
Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Cherry Hill
Hikma Pharmaceuticals USA Inc.
Portugal
Terrugem Snt
Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman
Hikma Pharmaceuticals LLC
11. KANCHAN HLTHCARE
Kanchan Healthcare Inc has filed for 2 different strengths of generic version for Cyclophosphamide. Given below are the
details of the strengths of this generic introduced by
Kanchan Hlthcare.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
25MG
capsule
Prescription
ORAL
AB
May 7, 2018
50MG
capsule
Prescription
ORAL
AB
May 7, 2018
12. NEXTSOURCE
Nextsource Biotechnology Llc has filed for 2 different strengths of generic version for Cyclophosphamide. Given below are the
details of the strengths of this generic introduced by
Nextsource.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
25MG
capsule
Prescription
ORAL
AB
Dec 3, 2024
50MG
capsule
Prescription
ORAL
AB
Dec 3, 2024
13. NEXUS
Nexus Pharmaceuticals Llc has filed for 2 different strengths of generic version for Cyclophosphamide. Given below are the
details of the strengths of this generic introduced by
Nexus.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
500MG/2.5ML (200MG/ML)
solution
Prescription
INTRAVENOUS
AP
Oct 29, 2024
1GM/5ML (200MG/ML)
solution
Prescription
INTRAVENOUS
AP
Oct 29, 2024
Manufacturing Plant Locations
New
Nexus's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Nexus as present at those locations.
Country
City
Firm Name
United States
Le Roy
Nexus Cooperative
Lenexa
Nexus Medical LLC
Lincolnshire
Nexus Pharmaceuticals, LLC
San Diego
Nexus Dx, Inc
Rose Creek
Nexus Cooperative
Santa Fe Springs
Nexus Foods, Inc.
Salt Lake City
Nexus Spine, LLC
Lansing
Nexus Cooperative
Cottonwood Heights
Nexus CMF, LLC
Alden
Nexus Cooperative
Conger
Nexus Cooperative
Bedford Park
Nexus Distribution Corp.
Emmons
Nexus Cooperative
Pleasant Prairie
Nexus Pharmaceuticals Inc
Adams
Nexus Cooperative
Cerritos
Nexus Foods Inc
Bedford Park
Nexus Distribution Corporation
Brownsdale
Nexus Cooperative
14. ROXANE
Roxane Laboratories Inc has filed for 2 different strengths of generic version for Cyclophosphamide. Given below are the
details of the strengths of this generic introduced by
Roxane.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
50MG
tablet
Discontinued
ORAL
N/A
Aug 17, 1999
25MG
tablet
Discontinued
ORAL
N/A
Aug 17, 1999
15. SAGENT PHARMS INC
Sagent Pharmaceuticals Inc has filed for 3 different strengths of generic version for Cyclophosphamide. Given below are the
details of the strengths of this generic introduced by
Sagent Pharms Inc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
1GM/VIAL
injectable
Prescription
INJECTION
AP
Jul 17, 2023
500MG/VIAL
injectable
Prescription
INJECTION
AP
Jul 17, 2023
2GM/VIAL
injectable
Prescription
INJECTION
AP
Jul 17, 2023
16. SUNNY
Sunny Pharmtech Inc has filed for 3 different strengths of generic version for Cyclophosphamide. Given below are the
details of the strengths of this generic introduced by
Sunny.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
2GM/VIAL
injectable
Prescription
INJECTION
AP
Oct 26, 2023
500MG/VIAL
injectable
Prescription
INJECTION
AP
Oct 26, 2023
1GM/VIAL
injectable
Prescription
INJECTION
AP
Oct 26, 2023
Manufacturing Plant Locations
New
Sunny's manufacturing plants are situated in 3 countries - United States, China, Belgium. Given below are the details of these plant locations as well as the firm names of Sunny as present at those locations.
Country
City
Firm Name
United States
Alhambra
SUNNY H. INTERNATIONAL CORP
San Jose
Sunny Egg Company, Inc
Burien
SUNNY-HKV INVESTMENTS LLC
Rochester
Sunny Brook Poultry - Rufus Ramer
De Soto
Sunny Days Farm
Delta
Sunny Boys Dairy
Fresno
Sunnyland Bulgur Wheat Inc.
Amsterdam
Sunnybrook Farm Herbs Inc
Manheim
Sunny Hill Farm
Tampa
Sunny Florida Dairy, Inc.
Fort Benton
Sunnybrook Colony Inc
Dayton
Sunny Delight Beverages Company
Albany
Sunnyland Farms Inc
Auburn
Sunny Hollow Farms
Blue Ash
Sunny Delight Beverages Company - Office Headquarters
Sherman
Sunny Delight Beverages Co.
Shreveport
Sunny Hussain
Tryon
Sunny Creek Farm Inc.
Oxford
Sunny Dell Specialty LLC
Littleton
Sunny Delight Beverages Company
Atlanta
Sunny Delight Beverages Co-Atlanta
Buttonwillow
SunnyGem, LLC
Wasco
SunnyGem, LLC
Craig
Sunny Breeze Farm
China
WEIFANG
Sunnycal (Weifang) Company, Ltd.
Belgium
Turnhout
Sunnyland
17. TEVA PARENTERAL
Teva Parenteral Medicines Inc has filed for 5 different strengths of generic version for Cyclophosphamide. All of these versions come by the name NEOSAR. Given below are the
details of the strengths of this generic introduced by
Teva Parenteral.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
1GM/VIAL
injectable
Discontinued
INJECTION
N/A
Apr 29, 1993
200MG/VIAL
injectable
Discontinued
INJECTION
N/A
Apr 29, 1993
100MG/VIAL
injectable
Discontinued
INJECTION
N/A
Apr 29, 1993
500MG/VIAL
injectable
Discontinued
INJECTION
N/A
Apr 29, 1993
2GM/VIAL
injectable
Discontinued
INJECTION
N/A
Apr 29, 1993
Manufacturing Plant Locations
New
Teva Parenteral's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Teva Parenteral as present at those locations.
Country
City
Firm Name
United States
Irvine
Teva Parenteral Medicines, Inc.
18. XGEN PHARMS
Xgen Pharmaceuticals Djb Inc has filed for 3 different strengths of generic version for Cyclophosphamide. Given below are the
details of the strengths of this generic introduced by
Xgen Pharms.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
500MG/VIAL
injectable
Prescription
INJECTION
AP
Oct 18, 2022
2GM/VIAL
injectable
Prescription
INJECTION
AP
Oct 18, 2022
1GM/VIAL
injectable
Prescription
INJECTION
AP
Oct 18, 2022
19. ZYDUS LIFESCIENCES
Zydus Lifesciences Ltd has filed for 2 different strengths of generic version for Cyclophosphamide. Given below are the
details of the strengths of this generic introduced by
Zydus Lifesciences.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
25MG
capsule
Prescription
ORAL
AB
Dec 13, 2023
50MG
capsule
Prescription
ORAL
AB
Dec 13, 2023
Manufacturing Plant Locations
New
Zydus Lifesciences's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Zydus Lifesciences as present at those locations.
